These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 19405173)

  • 1. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists.
    Adorini L; Penna G
    Hum Immunol; 2009 May; 70(5):345-52. PubMed ID: 19405173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
    Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
    Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells.
    Sochorová K; Budinský V; Rozková D; Tobiasová Z; Dusilová-Sulková S; Spísek R; Bartůnková J
    Clin Immunol; 2009 Oct; 133(1):69-77. PubMed ID: 19660988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.
    Adorini L; Penna G; Giarratana N; Uskokovic M
    J Cell Biochem; 2003 Feb; 88(2):227-33. PubMed ID: 12520519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological induction of tolerogenic dendritic cells and regulatory T cells.
    Adorini L; Giarratana N; Penna G
    Semin Immunol; 2004 Apr; 16(2):127-34. PubMed ID: 15036236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-dihydroxyvitamin D
    Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
    Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor agonists in the treatment of autoimmune diseases: selective targeting of myeloid but not plasmacytoid dendritic cells.
    Penna G; Amuchastegui S; Laverny G; Adorini L
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V69-73. PubMed ID: 18290726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes.
    Adorini L
    Ann N Y Acad Sci; 2003 Apr; 987():258-61. PubMed ID: 12727648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating tolerogenic dendritic cells with neuropeptides.
    Delgado M
    Hum Immunol; 2009 May; 70(5):300-7. PubMed ID: 19405171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of herpesvirus entry mediator in 1,25-dihydroxyvitamin D3-treated mouse bone marrow-derived dendritic cells promotes the generation of CD4⁺CD25⁺Foxp3⁺ regulatory T cells.
    Huang Y; Zhao Y; Ran X; Wang C
    Mol Med Rep; 2014 Mar; 9(3):813-8. PubMed ID: 24366217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells.
    Penna G; Amuchastegui S; Giarratana N; Daniel KC; Vulcano M; Sozzani S; Adorini L
    J Immunol; 2007 Jan; 178(1):145-53. PubMed ID: 17182549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells.
    Boks MA; Zwaginga JJ; van Ham SM; ten Brinke A
    Scand J Immunol; 2010 Aug; 72(2):158-68. PubMed ID: 20618775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype
    Brusko MA; Stewart JM; Posgai AL; Wasserfall CH; Atkinson MA; Brusko TM; Keselowsky BG
    Front Immunol; 2020; 11():574447. PubMed ID: 33193362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10-producing T cells.
    Bakdash G; van Capel TM; Mason LM; Kapsenberg ML; de Jong EC
    Vaccine; 2014 Oct; 32(47):6294-302. PubMed ID: 25236584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Ambivalence of Dendritic Cells: Tolerogenicity and Immunogenicity.
    Nam JH; Lee JH; Choi SY; Jung NC; Song JY; Seo HG; Lim DS
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intervention in autoimmunity: the potential of vitamin D receptor agonists.
    Adorini L
    Cell Immunol; 2005 Feb; 233(2):115-24. PubMed ID: 15936743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands.
    Adorini L; Penna G; Giarratana N; Roncari A; Amuchastegui S; Daniel KC; Uskokovic M
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):437-41. PubMed ID: 15225816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol.
    Ghoreishi M; Bach P; Obst J; Komba M; Fleet JC; Dutz JP
    J Immunol; 2009 May; 182(10):6071-8. PubMed ID: 19414758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells.
    Cong Y; Wang L; Konrad A; Schoeb T; Elson CO
    Eur J Immunol; 2009 Nov; 39(11):3134-46. PubMed ID: 19839007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.